Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 03    source : Www.biospace.com    save search
aTyr Pharma to Present at Upcoming Investor Conferences in March
Published: 2022-03-03 (Crawled : 00:00) - biospace.com/
LIFE | $1.64 170K twitter stocktwits trandingview |
Health Technology
 | | O: -0.68% H: 0.0% C: 0.0%
conference pharma
PhenoVista Biosciences Announces Michelle Mack as VP of Business Development
Published: 2022-03-03 (Crawled : 00:00) - biospace.com/
CSBR | $5.04 -0.4% 2K twitter stocktwits trandingview |
Health Technology
 | | O: 3.62% H: 0.0% C: 0.0%
pheno bioscience
First Wave BioPharma Announces Poster Presentation at the 2022 Digestive Disease Week (DDW) Conference
Published: 2022-03-03 (Crawled : 00:00) - biospace.com/
FWBI | $3.28 12.72% 100K twitter stocktwits trandingview |
Manufacturing
 | | O: -3.42% H: 0.0% C: 0.0%
biopharma conference presentation disease
Geron to Announce Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
Published: 2022-03-03 (Crawled : 00:00) - biospace.com/
GERN | $3.6 -3.49% 3.9M twitter stocktwits trandingview |
Health Technology
 | | O: 1.89% H: 0.0% C: 0.0%
financial results results
Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
LBPH | $20.59 10.28% 170K twitter stocktwits trandingview |
Manufacturing
 | | O: -5.21% H: 2.33% C: -7.72%
als financial results report results
Histogen to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Business Update
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
HSTO 4 d | $0.5 67.46% 530 twitter stocktwits trandingview |
Health Technology
 | | O: 3.17% H: 1.78% C: -6.44%
financial results report results
Evofem Biosciences Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
EVFM | $0.0159 160K twitter stocktwits trandingview |
Health Technology
 | | O: -3.71% H: 0.0% C: 0.0%
financial results report bioscience results
Tyra Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
TYRA | $16.055 3.58% 32K twitter stocktwits trandingview |
Health Technology
 | | O: -2.51% H: 0.86% C: -7.9%
financial results report bioscience results
NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
NXTC | $1.635 1.55% 67K twitter stocktwits trandingview |
Health Technology
 | | O: 1.66% H: 1.63% C: -2.65%
financial results report results
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K twitter stocktwits trandingview |
Health Technology
 | | O: 1.16% H: 0.0% C: -6.9%
biotech financial results report results iot
IO Biotech Announces Appointment of David V. Smith to its Board of Directors
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
IOBT | $1.48 2.78% 20K twitter stocktwits trandingview |
| | O: 0.59% H: 0.0% C: 0.0%
CDXS | $2.915 1.92% 74K twitter stocktwits trandingview |
Process Industries
 | | O: -1.05% H: 3.05% C: 2.69%
ces biotech iot
X4 Pharmaceuticals to Present at March Investor Conferences
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
XFOR | $1.335 -1.84% 1.2M twitter stocktwits trandingview |
Health Technology
 | | O: 10.15% H: 5.99% C: -2.3%
als conference
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
OTLC | $0.0394 3.5K twitter stocktwits trandingview |
Manufacturing
 | | O: -3.8% H: 3.95% C: 3.95%
arcus
Viridian Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Investor Conference Call on March 10, 2022
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
VRDN | $14.57 1.89% 120K twitter stocktwits trandingview |
Health Care and Social Assistan...
 | | O: 2.25% H: 2.54% C: -2.25%
financial results conference therapeutics report results
Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
CRVS | $1.495 3.82% 90K twitter stocktwits trandingview |
Health Technology
 | | O: 2.38% H: 0.0% C: -5.81%
als financial results report results
Satsuma Pharmaceuticals Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2022 Annual Meeting
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
STSA | $1.1 -0.9% -0.91% 0 twitter stocktwits trandingview |
Health Technology
 | | O: 4.11% H: 0.0% C: -2.63%
america als ces presentation
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
AZNCF | News | $138.73 3.7K twitter stocktwits trandingview |
Health Technology
 | | O: -5.26% H: 0.0% C: 0.0%
AZN | News | $70.87 1.06% 3M twitter stocktwits trandingview |
Health Technology
 | | O: -2.63% H: 0.9% C: -0.3%
als financial results report results
Annexon Biosciences to Present Preclinical Data Supporting Complement Inhibitor Programs for the Treatment of Guillain-Barré Syndrome and Huntington’s Disease at AAN 2022
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
ANNX | $4.6 1.21% 260K twitter stocktwits trandingview |
Health Technology
 | | O: 1.3% H: 0.0% C: -6.21%
huntington treatment program disease preclinical bioscience syndros pre-clinical huntington’s disease
Rain Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Progress
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
RAIN | $1.21 0.0% 3.7M twitter stocktwits trandingview |
Manufacturing
 | | O: 2.9% H: 0.0% C: -10.76%
financial results therapeutics report results
Evogene to Attend the 34th Annual ROTH Investor Conference in Dana Point California Between March 13-15, 2022
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
EVGN | $0.7 -13.64% 63K twitter stocktwits trandingview |
Health Technology
 | | O: -0.76% H: 0.77% C: -9.23%
california conference
Gainers vs Losers
87% 13%

Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M twitter stocktwits trandingview |

AGBA | $2.61 108.8% 41M twitter stocktwits trandingview |
Finance
CZOO | $9.32 86.77% 18M twitter stocktwits trandingview |

EDBL | News | $6.7 78.19% 1.7M twitter stocktwits trandingview |

OPRT | News | $3.37 49.78% 8.9M twitter stocktwits trandingview |
Finance
MTC | $2.14 37.18% 4.9M twitter stocktwits trandingview |
Technology Services
VNRX | $0.8 33.33% 2.9M twitter stocktwits trandingview |
Health Technology
MLEC | $1.79 27.86% 2.6M twitter stocktwits trandingview |
n/a
PALI | $6.29 27.59% 22M twitter stocktwits trandingview |
Manufacturing
MCRB | $0.7902 26.51% 6.9M twitter stocktwits trandingview |
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.